Download file to see previous pages...
Benign prostatic hypertrophy is a nonmalignant growth of the prostate that is generated by overgrowth of the fibromuscular and epithelium flesh of the peri-urethral zone and the transition area. This illness is common in men aged fifty years and above. Its clinical presentation includes obstruction of urine flow, urethra compression, frequent urination, not being able to start urinating and leaking and urgency or dribbling (Zhou, Netto & Epstein, 2012). In regard to diagnostic testing, microscopic hematuria initial evaluation is done on a patient, the presence of palpable induration or nodularity of the prostate on digital rectal assessment reveals the condition. Prostate cancer does not cause any signs at all and can present at any level of the illness. In most cases, the cancer occurs in the prostate gland periphery and the signs arise when they have developed to compress the urethra or attack the sphincter. The prostate cancer presents in urinary tract obstruction (LUTS) symptoms. The LUTS is in three distinct groups associated with the post-micturition symptoms, storage of urine and voiding (Tewari, 2013). In regard to diagnostic testing, prostate cancer is diagnosed using imaging techniques such as MRI to detect tumors that are clinically significant.
The treatment of prostatitis is difficult because of the presence of inhibited penetration of most antibiotics across prostatic epithelium and through the non-fenestrated prostatic capillaries to the infected fluids and tissues. The patient must be advised that the preferred drug is fluoroquinolone because of its quality of good penetration through the prostate. The time of antibiotic therapy is usually 2-4 weeks, and that depends on the severe nature of the illness. The patient is then reviewed for clinical symptoms and signs (Koda-Kimble & Alldredge, 2013).
When patients suffer from mild symptoms of benign prostatic hypertrophy there no need for alarm but they should be
...Download file to see next pagesRead More
The cancerous cell spread to other parts of the body and can cause pain, difficulty in urinating, problems during sexual intercourse, or erectile dysfunction (American Cancer Society, 2010). Though the specific cause of prostate cancer remains unknown, several factors such as diet, genetic, medication exposure and viral infection, have been implicated in its development.
1. What are the components of physical examination? Describe each component.
The physical examination for prostate cancer has two main components, namely Digital Rectal examination (DRE) and measuring blood levels of Prostate Specific Antigen (PSA). Digital Rectal examination is undertaken as a part of annual examination to directly palpate the prostate and check for abnormal texture and presence of lumps.
This paper aims to provide enlightened understanding of prostate cancer and the men who have acquired this disease.
In this paper, the pathology of this cancer will be discussed in order to have a thorough understanding of what a man with this type of cancer is undergoing.
According to the definition of the US National Institute of Health, it is a type of cancer that "forms in tissues of the prostate (a gland in the male reproductive system found below the bladder and in front of the rectum). Prostate cancer usually occurs in older men." (Definition of prostate cancer) Prostate is a part of the male reproductive system which is located in front of the rectum and underneath the urinary bladder and surrounds the urethra.
Cancer occurs when specific cells in the body of the patient start multiplying. The multiplication is abnormal and uncontrolled (NMA, 2008). The reason why these cells start acting this way is not yet well known. It is suspected that it is a result of mutation, whereby the genetic make-up of the cell is affected, making the cell "to go mad" (Rosenberg et al, 2008).
Radiotherapy (RT) is perhaps the most common treatment of choice in patients with PC. However, results of treatment of PC are rather disappointing. A probable explanation for this could lie in the fact that more than 50% of PCs are seen in men 75 years of age.
This paper will discuss the relevant anatomy and physiology of the prostate and surrounding structures, the pathophysiology and management of prostate cancer, the use of radiotherapy for prostate cancer, and the localisation modalities to be
According to data that was just released by the U.S. Center for Disease Control and Prevention (CDC), there are about sixteen million Americans ailing from the disease. This represents a ten percent increase in the number of cases present
The use of brachy therapy for the treatment of prostrate cancer has been through a lot of evolutions. Primarily, researchers have looked at the effect of using the therapy alone as against using it together with other external medical aids. The evolution did not, however, happen without any challenges.